Key result
Beta-arrestin-recruited PDE4 desensitizes the agonist-dependent coupling of beta2-AR with Gi and its consequential activation of ERK by attenuating AKAP79-tethered PKA activity.
Population
Preclinical model using dominant-negative and siRNA-mediated knockdown strategies
Design
Preclinical
Authors
Loading...
No immediate clinical implications for beta-agonists; leaves open PDE4-beta-arrestin modulation of beta2-AR-Gi-ERK coupling in disease models.
This study uncovers a novel mechanism of beta2-adrenoceptor regulation where beta-arrestin-recruited PDE4 desensitizes its coupling to G(i) and subsequent ERK activation.
Baillie et al. (2005) studied this question. Dominant-negative and siRNA-mediated knockdown of PDE4 isoforms was evaluated on beta2-AR signaling to activation of ERK. Beta-arrestin-recruited PDE4 desensitizes the agonist-dependent coupling of beta2-AR with Gi and its consequential activation of ERK by attenuating AKAP79-tethered PKA activity.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: